Programmed cell death, or apoptosis, is a physiological cell suicide mechanism, which is triggered in the cells by different stimuli. It has been shown that proteases play a significant role both in the target cell killing by cytotoxic lymphocytes and in the TNF-or anti-Fas-induced cell death. The proteases involved in the early (induction) and late (cell self-destruction) stages of apoptosis are reviewed. It is suggested that the late stages are connected with the activation of a cascade of intracellular proteases, which leads to massive protein destruction. It is likely that the protein destruction is mainly designed for preventing autoimmune response to proteins released from dying cells.
Phenomenon and pathways of activation of apoptosis
Apoptosis, the physiological mode of cell death, is representative of an endogenous cell suicide mechanism, which can be selectively triggered by cells in response to as yet largely unknown stimuli. It is an essential element of normal development of an organism. Apoptosis is observed during embryonic or fetal development or in cell turnover in normal adult tissue. In contract to necrosis, the cell actively participates in the process of its own death during apoptosis. The phenomenon of programmed cell death was described for the first time by Lockshin and Williams (1964) , Whitfield et al (1968) , Lockshin (1969) . This mode of cell death was recognized as being separate from other forms of cell death and defined as apoptosis by Kerr et al (1972) and Wyllie (1980) . Apoptotic cells have specific biochemistry and morphology. The cell rounds up, severing junctions with its neighbours and losing microvilli. At the same time, the cytoplasm condenses, and the endoplasmic reticulum dilates, probably as a result of a net shift of water from the cytoplasm, and forms the vesicles, giving a characteristic bubbling appearance. The chromatin rapidly forms dense crescent-shaped aggregates lining the nuclear membrane (Duvall and Wyllie, 1986) . One of the most well studied biochemical hallmarks of apoptosis is activation of Ca 2+ , Mg 2+ -nuclease, which causes the internucleosomal cleavage of nuclear chromatin. This results in appearance of low-molecular DNA fragments, whose size varies proportionally to the size of a nucleosome. When separated by electrophoresis, these fragments form a typical`ladder'. The process of DNA degradation has been shown to involve three discrete stages: initially, to fragments of approximately 300 kb, followed by the appearance of 50 kb fragments, and, finally, formation of low-molecular oligonucleosomal fragments (Brown et al, 1993) .
The mechanisms of activation of apoptosis and, in particular, of endonucleases are still unknown. As it has been shown in many models of apoptosis, a proteolytic step is required prior to DNA cleavage by endonucleases (Bruno et al, 1992; Kaufman, 1989; Squier et al, 1994) . Therefore, proteases seem to play a principal role in initiating the programmed cell death. Apoptosis may be induced by exogenous proteases injected into a cell (external activation pathway) or triggered upon activation of intracellular proteases by certain stimuli (internal activation pathway). The first type is mediated by cytotoxic lymphocytes, whose granules contain perforin and a variety of serine proteases ± granzymes. Cell death induced by TNF, antibodies to Fas, or dexamethasone belongs to the second type. The mechanism is probably the same for the internal and external activation pathways. Injection of granzymes into the target cell may cause activation of endogenous proteases involved in the internal activation pathway.
proteases ± granzymes (A to G). In the presence of Ca 2+ , perforin binds to the cell membrane, penetrates its lipid bilayer, and polymerizes, forming a pore approximately 16 nm in diameter (Podack et al, 1989) , which facilitates the entry of proteolytic enzymes into the target cell.
Murine granzymes (specific cytotoxic proteinases) represent a gene family of seven members. They were originally identified as cytotoxic lymphocyte-specific genes, whose expession correlated with the induction of cytotoxicity (Lobe et al, 1986) . Their localization within the lymphocyte cytoplasmic granules has been established (Redmond et al, 1987) . The PCR analysis of granzymes B ± G in various T-cell activation models revealed that only granzyme B expression was correlated with the development of cytotoxicity in these cells (Prendergast et al, 1992) , suggesting that it may be a direct effector in the lytic process. Shi et al (1992) have shown that fragmentin-2 ± a serine protease purified from cytotoxic granules of rat natural killers and highly homologous to granzyme B ± is able to induce DNA fragmentation and apoptosis in target cells in the presence of perforin. Perforin alone failed to trigger apoptosis. The importance of perforin and granzyme B was confirmed by subsequent studies. Stably transfected antisense constructs for perforin and granzyme B essentially eliminated the lytic ability of a human cytotoxic lymphocyte (Bochan et al, 1995) . These results strongly indicate that both perforin and granzyme B are required by this human cytotoxic lymphocyte for effective lysis. Recently the role of granzyme B in activation of apoptotic pathways was reviewed by Greenberg (1996) .
Evidence also implicates granzyme A in the induction of apoptosis. The expression of antisense granzyme A mRNA significantly decreased the cytotoxicity of transfectant cytotoxic lymphocytes (Talento et al, 1992) . Moreover, the cotransfection of perforin and granzyme A into a noncytotoxic basophil leukemia cell line (RBL) endowed this cell line with the capacity to induce apoptosis in target cells (Shiver et al, 1992) . However, the data on the role of granzyme A in induction of apoptosis are rather controversial. Thus, Ebnet et al (1995) , generated granzyme Adeficient mouse mutants. Their in vitro-and ex vivo-derived cytotoxic T cells and natural killer cells were indistinguishable from those of normal mice in causing membrane disruption, apoptosis and DNA fragmentation in target cells. The authors suggest that granzyme A does not play a primary role in cell-mediated cytotoxicity, as has been assumed previously. The significance of proteases in activation of apoptosis has also been demonstrated in several studies using protease inhibitors. Thus, it has been shown that the cytotoxicity of cytotoxic lymphocytes and natural killers is strongly reduced by serine protease inhibitors present in the incubation medium (Chang et al, 1980; Hudig et al, 1981) . Serine protease inhibitors also decrease the lytic activity of the granules isolated from cytotoxic lymphocytes and of purified serine protease preparations enriched with perforin (Ewoldt et al, 1992) . Although the great deal of experimental data counts in favour of a key role of granzymes in cytotoxic lymphocyte-mediated apoptosis of target cells, the mechanism by which granzymes trigger target cell death and their specific intracellular substrates have not been completely established.
Activation of intracellular proteases during apoptosis, or internal activation pathway
This type of apoptosis is most often studied on the models of cell death induced by humoral factors-steroid hormones, TNF, anti-Fas antibodies.
Considering the similar apoptotic character of cell death triggered in a target cell by injection of CTL-derived granzymes or by physiological stimuli, Williams and Henkart (1994) examined the effects of cytoplasmic proteolysis on cells by using the techniques of osmotic lysis of pinosomes to introduce different proteases into cells. Such protease injection caused rapid cell death accompanied by DNA fragmentation and typical apoptotic morphological changes. These results suggest that activation of intracellular proteases by any molecular pathway could give rise to apoptotic cell death.
The increased protein degradation during the programmed cell death was detected by MacDonald et al (1980 MacDonald et al ( ,1981 in dexamethasone-treated lymphocytes. Voelkel-Johnson et al (1995) directly demonstrated the enhancement of lysis of several proteins in apoptotic cells. They measured proteolysis in the supernatants obtained after precipitation of total cell protein with 5% TCA by reaction of free primary amines with fluorescamine or by release of radioactively labeled leucine. Both the methods detected the increase in proteolytic activity in TNF-treated 3T3 cells.
Specific inhibitors have become an important tool in elucidating the role of proteases in apoptosis. It should be noted that chemically derived protease inhibitors may introduce artifacts related to their entry and distribution within the cell. Thus, Higuchi et al (1995) observed that two serine protease inhibitors abrogated the TNF-induced fragmentation of DNA and typical apoptotic morphological changes in a myelogenous cell line ML-1a; the maximum effect being observed in the presence of TPCK (Tos-Phe-CH2Cl) ± a hydrophobic inhibitor of chymotrypsin-like proteases. However, hydrophobic compounds may interact with the membrane or membrane proteins. Therefore, it is not improbable that the effect of TPCK may be due to its influence, for instance, on the activity of phospholipase A2, which is known to be involved in the toxic action of TNF (Neale et al, 1988) , but not to its protease-inhibiting properties. Kwo et al (1995) have reported that TLCK ± an inhibitor of trypsin-like serine proteases ± is effective in preventing bile acid-induced DNA fragmentation in hepatocytes. However, other inhibitors of serine and cysteine proteases were ineffective in these cells. It should be noted that accurate comparison of effects of different protease inhibitors is complicated, since their efficiency may depend upon such factors as their ability to penetrate into the cell (which is not reported for the inhibitors used) or their stability (e.g. the stability of TLCK in water solution at physiological pH is very low). At the same time, one should keep in mind that the specificity of different protease inhibitors is not absolute. For instance, many serine protease inhibitors also inhibit cysteine proteases and vice versa. Chow et al (1995) have shown that cell lysates prepared from anti-Fas stimulated Jurkat T cells induced chromatin fragmentation in isolated thymocyte nuclei. The formation of such activity in Jurkat T cells was almost completely blocked by the inhibitors of serine proteases as well as those of ICE. Therefore, the use of protease inhibitors as the only tool does not allow to elucidate the type of proteases involved in the programmed cell death unambiguously.
In spite of the rapidly growing interest in the model of Fasinduced apoptosis, its mechanism is at present unclear. The Fas (Apo-1/CD95) antigen is a cell surface receptor belonging to the TNF family. It is a 48 kDa transmembrane glycoprotein (Oehm et al, 1992) , and its cytoplasmic domain contains a region of significant sequence homology with the TNF receptor p55 (Itoh et al, 1991) .
To date, it has been shown that one of the mediators of this activation mechanism is ICE ± interleukin 1-bconverting enzyme or caspase-1. ICE is a cytoplasmic protease originally found in monocytes, which cleaves the IL-1b precursor (31 kDa) with formation of the mature IL-1b (17 kDa). Overexpression of ICE causes apoptosis of fibroblasts (Miura et al, 1993) . Moreover, overexpression of Ced-3 ± a protein from Caenorhabditis elegans, which belongs to the ICE family ± also induced apoptosis . Recently, the increase in proteolytic activity of ICE has been demonstrated with the use of its specific fluorescent substrate ± DABCYL-YVADAP-EDANS. A marked hydrolysis of the substrate recorded by the increase in fluorescence was observed already within first 10 min after addition of anti-Fas antibodies (Los et al, 1995) . As low as 10 nM of a specific ICE inhibitor ± tetrapeptide aldehyde YVAD-CHO (Km=0.76 nM) ± almost completely inhibited the Fas-induced cell death. The transient transfection of cells with ICE constructs considerably increased the number of apoptotic cells, whereas CrmA (CrmA is a virus protein inhibitor of ICE) or ICE antisense constructs had the opposite effect (Los et al, 1995) . These data are well consistent with those obtained by Enarl et al (1995) who have shown that an ICE inhibitor YVAD-chloromethylketone (YVAD-CMK) blocks cell death, although at much higher concentrations than YVAD-CHO. In addition, the authors have demonstrated the ability of the virus protein CrmA to prevent the TNF-or anti-Fasmediated cell death. The Rat-2 (rat fibroblast) transformants which expressed only human Fas were efficiently killed by TNF or anti-Fas. However, the transformant clones that expressed CrmA were resistant to such treatment.
Therefore, proteases play a key role in activation of apoptosis by both activation pathways. The proteolytic activity of several cellular proteases is increased as supported by the experiments with protease inhibitors. The activation of proteases causes degradation of several cell proteins, thus resulting in apoptotic biochemical and morphological changes.
Speci®city of proteases involved in apoptosis
The important role of serine proteases ± a family of proteolytic enzymes with serine in their active center ± in induction of apoptosis has been well documented. Most granzymes are classified as serine proteases. According to their substrate specificity, the serine proteases may be divided into three large subgroups. Elastase-like enzymes cleave their protein substrates at non-charged non-aromatic amino acid residues (alanine, valine, glycine, etc.). Trypsin-like proteases (tryptases) cleave at positively charged amino acids (lysine, arginine). Chymotrypsin-like proteases (chymases) cleave at aromatic amino acid residues. There are also highly specific enzymes, which cleave a protein molecule at a single amino acid. For instance, granzyme B is an asparaginase, since it cleaves only at asparagine.
The experiments made with the use of serine protease inhibitors support their dominant role in various models of apoptosis. Walker and Sikorska (1993) showed that several serine protease inhibitors (PMSF, DCI, TPCK) inhibited DNA fragmentation in thymocytes, whereas cysteine protease inhibitors (leupeptin, E64) did not. The cytoplasmic overexpression of a high-molecular serine protease inhibitor prevented the TNF-induced apoptosis (Kumar and Baglioni, 1991 ). In the above cited work by Chow et al (1995) , the inhibitors of serine proteases and ICE were equally effective in inhibiting the formation of apoptotic nuclei promoting activity in anti-Fas treated Jurkat T cells, but only a specific chymase inhibitor (TPCK) was able to prevent the apoptosis in the isolated nuclei treated with the Jurkat T cell extracts. These data also suggest that chymase, which immediately induces DNA fragmentation, itself must be activated by other proteolytic enzymes, probably, of different families, as demonstrated by the use of protease inhibitors with different specificity. This implies the existence of a cascade of proteases involved in activation of apoptosis in a cell. The significance of chymases in apoptosis is also supported by the experiments of Woodard et al (1994) who found that a specific biotinylated chymase inhibitor ± Bi-Aca-Aca-Phe-Leu-Phe P (Oph)2, which irreversibly binds to chymases, inhibited natural killer-mediated target cell lysis in a dose-dependent manner. Using the Western blot analysis, the authors identified a single 30 kDa protein capable to bind to this inhibitor.
Although a great number of publications on the role of serine proteases have been accumulated, only few were successful in identifying individual enzymes. Schlegel et al (1995) partially purified a protease from the cytoplasm of Jurkat T cells undergoing anti-Fas induced apoptosis and clearly demonstrated its belonging to the serine protease family. A 24 kDa elastase-like serine protease has been purified from apoptotic U937 cells (Wright et al, 1994) . The activity of this enzyme was more than tenfold higher in the apoptotic cells as compared to the control ones. In addition, the enzyme was able to trigger DNA fragmentation in isolated U937 nuclei.
Among the cysteine proteases, the role of ICE has been extensively studied. ICE is an asparaginase, i.e. it cleaves a protein molecule at asparagine. Asparaginases are relatively uncommon enzymes. Apart from ICE, only granzyme B, which belongs to the serine protease family, has been known among asparaginases related to apoptosis. However, granzyme B is not able to cleave the IL-1b precursor (Irmler et al, 1995) , which indicates its higher specificity. Several other ICE-like proteases participating in activation of apoptosis have been described in many cells. One of the most widely known ICE-like proteins is CPP32 or caspase-3 (Fernandes et al, 1994) . This protein has been cloned from Jurkat T cells and found to be highly expressed in cell lines of lymphocytic origin. Overexpression of CPP32 or ICE in Sf9 cells caused the development of some apoptotic features in them. However, there are two possible interpretations of this and similar experiments on artificial overexpression of proteases in the cells. One is that the given protease is a part of endogenous death pathway, and its overexpression specifically activates the programmed cell death. Another possibility is that the death of a cell results from significant non-physiological protein destruction by overexpressed proteases. A protein of the ICE family similar to CPP32 has been described by Tewari et al (1995b) . Although ICE has been found both in mice and in humans (Nett-Fiordalisi et al, 1992; Cerretti et al, 1994) , CPP32 analog has not been discovered in mice. In mice, the product of the gene nedd2 ± a cysteine protease, which is an inductor of apoptosis (Kumar et al, 1994 ), ± has been described. This protein has a 25% homology to the human CPP32 (which is maximum as compared to its homology with other cysteine proteases), whereas the homology between the murine and human ICEs is about 60%.
Protein targets for proteases and a hypothetical mechanism of cell death
In view of the foregoing, we can conclude that there exists a cascade of proteases involved in activation of apoptosis in the cell. Its enhancement with exogenously added proteases or inhibition by protease inhibitors would modulate the activation of programmed cell death. However, it seems necessary to distinguish between early and late, or advanced, stages of apoptosis. The early stage is characterized by initiation of the cascade of proteases-activation of certain cellular proteases and may be inhibited by highly specific inhibitors. The ability of specific inhibitors of ICE-like proteases to block apoptosis in different kinds of organisms suggests the central and conservative role of these proteases in apoptosis.
Little is known about the mechanism of activation of ICE. Chinnaiyan et al (1995) identified a protein FADD, which was able to bind to the cytoplasmic domain of Fas. Overexpression of FADD in MCF-7 or BJAB cells induced their apoptosis, which, similarly to Fas-activated apoptosis, was blocked by a specific ICE inhibitor CrmA. Therefore, FADD is likely an intermediate between Fas and ICE. Recently Boldin et al (1996) cloned a novel ICE/CED-3 protease, MACH or caspase-8, which binds to FADD. Its activity appears to be required for FAS and p55-R-induced cytotoxicity. It is likely caspase-8 is enzyme responsible for activating a protease cascade after Fas-receptor ligation, leading to death. However, the mechanisms of activation of the proteases by receptors have not yet been established.
Because of its secretory nature, the interleukin 1 precursor, which is cleaved by ICE, is unlikely to play a noticeable role in apoptosis. One of the targets for ICE-like proteases is poly(ADP-ribose) polymerase (PARP) (Tewari et al, 1995b) . PARP is involved in repairing damaged DNA, therefore, its proteolytic inactivation accelerates apoptosis. The authors cloned an ICE-related gene. The protein thus obtained cleaved PARP to generate the 85 kDa fragment typically found during apoptosis. Cleavage of PARP by this protein was inhibited by CrmA, but not by an inactive point mutant of CrmA. Furthermore, CrmA blocked cleavage of PARP in the dying cells. These experiments prove that PARP ± a DNA-repairing enzyme ± is one of the primary targets for ICE-like proteases.
One of the targets for granzyme B is an intracellular cysteine protease CPP32, which belongs to the ICE family. Darmon et al (1995) have shown that granzyme B cleaves and activates CPP32, the precursor of the protease responsible for cleavage of poly(ADP-ribose) polymerase. It is possible that PARP is not the single target for CPP32. Therefore, entering the target cell, granzyme B may activate the intracellular cascade of proteases. The ICElike proteases are its key elements, which link (unite) external and internal pathways of apoptosis activation.
Using cell-free extracts, Lazebnik et al (1995) have shown that cleavage of the nuclear lamin during apoptosis requires the action of a second ICE-like enzyme, which exhibits kinetics of cleavage and a profile of sensitivity to specific inhibitors that is distinct from the PARP proteinase. Thus, multiple ICE-like enzymes are required for apoptotic events. Inhibition of the lamin proteinase with tosyllysinè chloromethyl ketone' blocks nuclear apoptosis prior to the packaging of condensed chromatin into apoptotic bodies. Under these conditions, the nuclear DNA is fully cleaved to a nucleosomal ladder. The authors conclude that the lamin proteinase and the fragmentation nuclease function in independent parallel pathways during the final stages of apoptotic execution.
Fragmentation of DNA may be a result of the proteolytic activation of endonucleases, as demonstrated by Chow et al (1995) , who have found that the protease-containing cytoplasmic fraction from apoptotic cells induces fragmentation of DNA in isolated nuclei. It is likely that a serine protease belonging to the cascade of intracellular proteases migrates into the nucleus, where it activates nucleases.
The activated cascade of proteases cleaves a large number of intracellular substrates and, therefore, induces alteration of cell morphology characteristic of the late stages of apoptosis, and the addition of different protease inhibitors significantly reduces these morphological and biochemical changes. The rounding of the cells and their detachment from the substrate may result from destruction of the cytoskeleton. Indeed, Suarez-Huerta et al (1995) have demonstrated the degradation of cytoskeleton proteins during the TNF-induced apoptosis. CasciolaRosen et al (1995) observed the apoptosis-related destruction of DNA-dependent protein kinase. Tewari et al (1995a) observed the destruction of the 70 kDa protein component of U1 small nuclear ribonucleoprotein during Fas-and TNF-induced apoptosis. Voelkel-Johnson et al (1995) have revealed degradation of several other proteins during apoptosis: topoisomerase, laminin B, histone H1, protein kinase C, phospholipase A2. It hardly can be suggested that all proteins are involved in signal pathway of apoptosis and degraded specifically. The targets of cysteine proteases and a scheme of their interaction during apoptosis have been described in details by Kumar and Lavin (1996) . It seems most probably that several proteases are activated or, possible, lysosomal enzymes are released as a result of cytoskeleton destruction. So Lockshin and Zaker (1994) observed the lysosomal destruction of cytoplasm at apoptosis of intrasegmental muscles and labial glands of Manduca sexta.
Since in most apoptotic models inhibitors of transcription and translation induce (Martin et al, 1990) or enhance apoptosis in dose-dependent manner (Voelkel-Johnson et al, 1995; Higuchi et al, 1995) , it is most probable that the cascade of proteases already exists in the cell and is not synthesized de novo. Activation of apoptosis leads to formation of active enzymes from their precursors. There may be an equilibrium maintained in the cell between degradation of proteins by proteases and their biosynthesis. Introduction of exogenous or activation of endogenous proteolytic enzymes as well as addition of inhibitors of protein synthesis may shift this equilibrium to the acceleration of protein degradation. The concentrations of physiologically active proteins are then decreased, resulting in a considerable metabolic injury: e.g. impairment of DNA repair by PARP, destruction of the cytoskeleton, presumably, loss of antioxidant defense (SOD etc.), alteration of the chromatin structure (histones), etc. Taken together, these damages cause the cell death.
Therefore, the early stages of activation of apoptosis are initiated by individual proteases, most probably, ICE-like enzymes, which are inhibited by highly specific protease inhibitors. ICE-like proteases activate an intracellular protease cascade. The ICE-activated proteases cascade destroy or activate various cell proteins. Thus, destruction of cytoplasmic proteins gives the typical apoptotic morphology. Proteolytic cleavage of endonucleases causes their activation followed by degradation of DNA. Therefore, at the late stages, the functioning of the whole cascade of cellular proteases is accompanied by non-specific destruction of several cellular proteins and leads to the cell death. It is likely that the protein destruction is mainly designed for preventing the immune response to intracellular proteins released from the cell after its disintegration. The antigenicity of proteins is decreased by proteolytic fragmentation before the cell membrane breakage.
